Breast cancer bone metastases: denosumab or zoledronic acid?

被引：0
|
作者：
Gabri van der Pluijm
机构：
[1] Leiden University Medical Center,Department of Urology J3
来源：
Nature Reviews Endocrinology | 2011年 / 7卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Bone metastases cause patient morbidity and mortality. A recent study compared denosumab with zoledronic acid for the treatment of bone metastases in advanced breast cancer. Denosumab seemed to be the front-runner, but is that the whole story?
引用
收藏
页码：134 / 135
页数：1
相关论文
共 50 条
  • [1] CANCER Breast cancer bone metastases: denosumab or zoledronic acid?
    van der Pluijm, Gabri
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2011, 7 (03) : 134 - 135
  • [2] Cost-Effectiveness of Denosumab Compared With Zoledronic Acid in Patients With Breast Cancer and Bone Metastases
    Xie, Jipan
    Diener, Melissa
    Sorg, Rachael
    Wu, Eric Q.
    Namjoshi, Madhav
    [J]. CLINICAL BREAST CANCER, 2012, 12 (04) : 247 - 258
  • [3] Zoledronic acid for the prevention of bone metastases in patients with breast cancer
    Coleman, R.
    Gralow, J.
    Bell, R.
    Lipton, A.
    [J]. EJC SUPPLEMENTS, 2004, 2 (03): : 74 - 75
  • [4] Financial impact of coverage for zoledronic acid and denosumab in cancer patients with bone metastases.
    Russell, M. W.
    Bell, M. J.
    Namjoshi, M.
    Miller, J. D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [5] Denosumab versus zoledronic acid for the treatment of breast cancer patients with bone metastases: results of a randomized phase 3 study
    Stopeck, A.
    Body, J. J.
    Fujiwara, Y.
    Lipton, A.
    Steger, G. G.
    Viniegra, M.
    Fan, M.
    Braun, A.
    Dansey, R.
    Jun, S.
    [J]. EJC SUPPLEMENTS, 2009, 7 (03): : 2 - 3
  • [6] A COMPARISON OF DENOSUMAB VERSUS ZOLEDRONIC ACID FOR THE PREVENTION OF SKELETAL-RELATED EVENTS IN BREAST CANCER PATIENTS WITH BONE METASTASES
    Fujiwara, Yasuhiro
    Stopeck, Alison
    de Boer, Richard
    Lichinitser, Mikhail
    Tonkin, Katia
    Yardley, Denise
    Fan, Michelle
    Jiang, Qi
    Jun, Susie
    Dansey, Roger
    Braun, Ada
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 12 - 12
  • [7] A Comparison of Denosumab Versus Zoledronic Acid for the Prevention of Skeletal-Related Events in Breast Cancer Patients with Bone Metastases
    Stopeck, A.
    de Boer, R.
    Fujiwara, Y.
    Lichinitser, M.
    Tonkin, K.
    Yardley, D.
    Fan, M.
    Jiang, Q.
    Jun, S.
    Dansey, R.
    Braun, A.
    [J]. CANCER RESEARCH, 2009, 69 (24) : 490S - 490S
  • [8] Denosumab and zoledronic acid treatment in patients with genitourinary cancers and bone metastases
    Costa, Luis
    Fizazi, Karim
    Saad, Fred
    Brown, Janet Elizabeth
    Von Moos, Roger
    Oudard, Stephane
    Sternberg, Cora N.
    Ganju, Vinod
    Miller, Kurt
    Wang, Huei
    Maniar, Tapan
    Braun, Ada
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [9] Denosumab in the treatment of breast cancer bone metastases
    Lipton, A.
    Paterson, A.
    Tonkin, K.
    Gao, G.
    Kinsey, A. C.
    Jun, S.
    [J]. CLINICAL & EXPERIMENTAL METASTASIS, 2008, 25 : 18 - 18
  • [10] Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
    Stopeck, Alison T.
    Lipton, Allan
    Body, Jean-Jacques
    Steger, Guenther G.
    Tonkin, Katia
    de Boer, Richard H.
    Lichinitser, Mikhail
    Fujiwara, Yasuhiro
    Yardley, Denise A.
    Viniegra, Maria
    Fan, Michelle
    Jiang, Qi
    Dansey, Roger
    Jun, Susie
    Braun, Ada
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (35) : 5132 - 5139
12345